These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16381085)

  • 1. Biomarkers for preterm birth.
    Mukhopadhyay R
    J Proteome Res; 2005; 4(6):1900. PubMed ID: 16381085
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation.
    Rüetschi U; Rosén A; Karlsson G; Zetterberg H; Rymo L; Hagberg H; Jacobsson B
    J Proteome Res; 2005; 4(6):2236-42. PubMed ID: 16335971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of midtrimester amniotic fluid to identify novel biomarkers for preterm delivery.
    Fotopoulou C; Kyeyamwa S; Linder M; Thieme D; Hartenstein S; Klein O; Dudenhausen JW; Henrich W; Kalache KD; Bamberg C
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2488-93. PubMed ID: 22827563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. About one-half of early spontaneous preterm deliveries can be identified by a rapid matrix metalloproteinase-8 (MMP-8) bedside test at the time of mid-trimester genetic amniocentesis.
    Kim SM; Romero R; Lee J; Chaemsaithong P; Lee MW; Chaiyasit N; Lee HJ; Yoon BH
    J Matern Fetal Neonatal Med; 2016; 29(15):2414-22. PubMed ID: 26643648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic Analysis of Early Mid-Trimester Amniotic Fluid Does Not Predict Spontaneous Preterm Delivery.
    Hallingström M; Lenco J; Vajrychova M; Link M; Tambor V; Liman V; Bullarbo M; Nilsson S; Tsiartas P; Cobo T; Kacerovsky M; Jacobsson B
    PLoS One; 2016; 11(5):e0155164. PubMed ID: 27214132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early- or mid-trimester amniocentesis biomarkers for predicting preterm delivery: a meta-analysis.
    Liu Y; Liu Y; Zhang R; Zhu L; Feng Z
    Ann Med; 2017 Feb; 49(1):1-10. PubMed ID: 27494609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis.
    Conde-Agudelo A; Papageorghiou AT; Kennedy SH; Villar J
    BJOG; 2011 Aug; 118(9):1042-54. PubMed ID: 21401853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amniotic Fluid Proteomics Analysis and In Vitro Validation to Identify Potential Biomarkers of Preterm Birth.
    Chen S; Wang W; Yan G; Liu M; Li M; Chen P; Ma Q; Zhang J; Tang Y; Zhou L; You D
    Reprod Sci; 2024 Jul; 31(7):2032-2042. PubMed ID: 38453771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofluid Metabolomics in Preterm Birth Research.
    Gil AM; Duarte D
    Reprod Sci; 2018 Jul; 25(7):967-977. PubMed ID: 29439621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-based proteomics for pre-eclampsia and preterm birth.
    Law KP; Han TL; Tong C; Baker PN
    Int J Mol Sci; 2015 May; 16(5):10952-85. PubMed ID: 26006232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Likelihood ratios for the prediction of preterm delivery with biomarkers.
    Hee L
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1189-99. PubMed ID: 21568946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical proteomics in obstetrics and neonatology.
    Klein J; Buffin-Meyer B; Mullen W; Carty DM; Delles C; Vlahou A; Mischak H; Decramer S; Bascands JL; Schanstra JP
    Expert Rev Proteomics; 2014 Feb; 11(1):75-89. PubMed ID: 24404900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive power of maternal serum and amniotic fluid CRP and PAPP-A concentrations at the time of genetic amniocentesis for the preterm delivery.
    Ozer KT; Kavak ZN; Gökaslan H; Elter K; Pekin T
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):187-90. PubMed ID: 16219520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amniotic fluid proteomic signatures of cervical insufficiency and their association with length of latency.
    Govia RNM; Birse KD; Sepehri S; Khafipour E; Menticoglou SM; Burgener AD; Poliquin V
    Am J Reprod Immunol; 2018 Nov; 80(5):e13030. PubMed ID: 30076666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of spontaneous preterm birth in women with cervical insufficiency: Comprehensive analysis of multiple proteins in amniotic fluid.
    Lee SM; Park KH; Jung EY; Cho SH; Ryu A
    J Obstet Gynaecol Res; 2016 Jul; 42(7):776-83. PubMed ID: 26990253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic Fluid Infection in Preterm Pregnancies with Intact Membranes.
    Myntti T; Rahkonen L; Nupponen I; Pätäri-Sampo A; Tikkanen M; Sorsa T; Juhila J; Andersson S; Paavonen J; Stefanovic V
    Dis Markers; 2017; 2017():8167276. PubMed ID: 28167848
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenomedullin concentration in second trimester amniotic fluid cannot be used as a predictor of preterm delivery.
    Iavazzo C; Tassis K; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D; Hadjithomas A; Vrachnis N; Malamitsi-Puchner A
    In Vivo; 2009; 23(6):1021-6. PubMed ID: 20023250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: Impact of mediators present in amniotic fluid on preterm labour.
    Vrachnis N; Karavolos S; Iliodromiti Z; Sifakis S; Siristatidis C; Mastorakos G; Creatsas G
    In Vivo; 2012; 26(5):799-812. PubMed ID: 22949593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of preterm delivery by second trimester inflammatory biomarkers in the amniotic fluid.
    Kesrouani A; Chalhoub E; El Rassy E; Germanos M; Khazzaka A; Rizkallah J; Attieh E; Aouad N
    Cytokine; 2016 Sep; 85():67-70. PubMed ID: 27289215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cervical-vaginal fluid proteome and possible biomarkers of preterm birth.
    Cottingham K
    J Proteome Res; 2007 Apr; 6(4):1241-2. PubMed ID: 17457988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.